These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 12814332)

  • 1. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
    Zahodne LB; Fernandez HH
    Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson disease psychosis: Update.
    Friedman JH
    Behav Neurol; 2013 Jan; 27(4):469-77. PubMed ID: 23242358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for psychosis in Parkinson's disease patients.
    Friedman JH
    Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
    Friedman JH
    J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Understanding of Psychosis in Parkinson's Disease.
    Ojo OO; Fernandez HH
    Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis in Parkinson's disease: therapeutic options.
    Hasnain M
    Drugs Today (Barc); 2011 May; 47(5):353-67. PubMed ID: 22013566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of newer antipsychotics on extrapyramidal function.
    Tarsy D; Baldessarini RJ; Tarazi FI
    CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approach.
    Friedman JH
    Expert Opin Pharmacother; 2024 Feb; 25(2):149-156. PubMed ID: 38344806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for depression and psychosis in Parkinson's disease.
    Poewe W; Seppi K
    J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson's Disease Psychosis: Systematic Review and Network Meta-Analysis.
    Yunusa I; Rashid N; Seyedin R; Paratane D; Rajagopalan K
    J Geriatr Psychiatry Neurol; 2023 Sep; 36(5):417-432. PubMed ID: 36720473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
    Iketani R; Kawasaki Y; Yamada H
    Biol Pharm Bull; 2017; 40(11):1976-1982. PubMed ID: 29093347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine.
    Abdul-Rahman T; Herrera-Calderón RE; Aderinto N; Kundu M; Wireko AA; Adebusoye FT; Ekerin O; Lawal L; Mykolaivna NI; Alexiou A; Almashjary MN; Perveen A; Ashraf GM
    J Integr Neurosci; 2024 Apr; 23(4):80. PubMed ID: 38682215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of psychosis in Parkinson's disease.
    D'Souza C; Gupta A; Alldrick MD; Sastry BS
    Int J Clin Pract; 2003 May; 57(4):295-300. PubMed ID: 12800461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease psychosis 2010: a review article.
    Friedman JH
    Parkinsonism Relat Disord; 2010 Nov; 16(9):553-60. PubMed ID: 20538500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
    Molho ES; Factor SA
    Curr Neurol Neurosci Rep; 2001 Jul; 1(4):320-8. PubMed ID: 11898537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.